Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect.

Trial Profile

Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Dec 2011

At a glance

  • Drugs Olanzapine; Quetiapine; Risperidone
  • Indications Mania; Schizophrenia
  • Focus Therapeutic Use
  • Acronyms UPTAQE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 16 Dec 2011 Actual patient number (387) added as reported by ClinicalTrials.gov.
    • 01 May 2009 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
    • 01 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top